T1	Participants 524 722	Fifty-nine patients with a mean age 10 years (range 3-17) took Creon 8,000 ms for 14 days and were then randomised to 28 days of Creon 8,000 ms followed by 28 days of Creon 10,000 MMS, or vice versa
T2	Participants 324 422	three-centre study investigated the preference of cystic fibrosis (CF) patients for these products
T3	Participants 835 876	51 of 54 patients who completed the study
